---
title: Long term follow-up of the STOPAGO study
date: '2024-10-30'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39476101/?utm_source=curl&utm_medium=rss&utm_campaign=journals&utm_content=7603509&fc=None&ff=20241030210336&v=2.18.0.post9+e462414
source: Blood
description: An open prospective, multicenter study enrolled 48 selected patients
  with chronic immune thrombocytopenia who achieved complete response for 1 year on
  thrombopoietin receptor agonists, half of the patients maintained a sustained response
  off treatment 4 years after treatment discontinuation. ...
disable_comments: true
---
An open prospective, multicenter study enrolled 48 selected patients with chronic immune thrombocytopenia who achieved complete response for 1 year on thrombopoietin receptor agonists, half of the patients maintained a sustained response off treatment 4 years after treatment discontinuation. ...